Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.17% | 1.64% | 3.85% | 5.23% | 4.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.17% | 1.64% | 3.85% | 5.23% | 4.72% |
| Cost of Revenue | 0.77% | 1.32% | 2.15% | 6.04% | 6.02% |
| Gross Profit | -0.13% | 1.80% | 4.72% | 4.82% | 4.08% |
| SG&A Expenses | -18.46% | -1.01% | 4.58% | 5.25% | 18.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.04% | 0.98% | 4.45% | 6.39% | 10.56% |
| Operating Income | 37.39% | 4.09% | 1.65% | 1.05% | -15.52% |
| Income Before Tax | -9.72% | -38.54% | -39.72% | -46.98% | -29.85% |
| Income Tax Expenses | 20.00% | 19.64% | 10.57% | 42.52% | 6.72% |
| Earnings from Continuing Operations | -16.79% | -48.71% | -48.26% | -56.34% | -35.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.79% | -48.71% | -48.26% | -56.34% | -35.14% |
| EBIT | 37.39% | 4.09% | 1.65% | 1.05% | -15.52% |
| EBITDA | 21.61% | 0.94% | -0.30% | 0.23% | -10.80% |
| EPS Basic | -15.72% | -48.18% | -48.17% | -56.71% | -35.34% |
| Normalized Basic EPS | 42.59% | 11.08% | 7.72% | 9.57% | -11.76% |
| EPS Diluted | -17.33% | -49.48% | -48.92% | -56.67% | -33.87% |
| Normalized Diluted EPS | 43.82% | 12.26% | 8.79% | 10.61% | -11.09% |
| Average Basic Shares Outstanding | -1.53% | -1.35% | -0.80% | -0.25% | 0.27% |
| Average Diluted Shares Outstanding | -2.31% | -2.31% | -1.66% | -1.04% | -0.48% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.18% | 0.92% | 0.92% | 1.29% | 0.55% |